Analyst Julian Harrison of BTIG maintained a Buy rating on Cullinan Management (CGEM – Research Report), retaining the price target of ...

Cullinan Management (CGEM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Soumit ...

Cambridge, Massachusetts Thursday, October 17, 2024, 17:00 Hrs [IST] ...

Rolls-Royce's Cullinan Series II has made its debut in Korea, with newest version of the ultraluxury SUV featuring new looks ...

SEOUL, Oct. 18 (Korea Bizwire) – Rolls-Royce Motor Cars introduced the latest iteration of its luxury sport utility vehicle, ...

Cullinan Therapeutics said the U.S. Food and Drug Administration approved its investigation new drug application for CLN-978, a potential treatment for lupus. The biopharmaceutical company said the ...

Nishad Hussain is the chairman of World Star, a prominent holding company based in Dubai. After years of living abroad, he has made the transition from his first car, an old Nissan Sunny, to owning ...

Cullinan Park is perfect for a fall outing. It offers places to walk with the kids, exercise the dogs or stroll in the woods.

The good folks over at RDB LA in Los Angeles, California, have done it again - they are proudly presenting on social media ...

该公司还获得澳大利亚人类研究伦理委员会批准,开始针对治疗系统性红斑狼疮 (SLE)的药物CLN-978的全球一期试验。尽管Morgan Stanley将Cullinan的目标价下调至38美元,但仍维持了对公司的增持评级。

有趣的是，Cullinan的股票显示出显著的动力，InvestingPro提示强调过去一年的价格回报率为95.23%。这一大幅增长表明市场对该公司的产品线（包括最近获FDA批准的CLN-978项目）持乐观态度。此外，该公司的资产负债表上现金多于债务，这可能为其推进临床试验提供财务灵活性。

The lowest-priced Rolls-Royce in the company's lineup gets an aesthetic and technological boost for the 2025 model year.